Two Sigma Investments, LP Alkermes Plc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 405,659 shares of ALKS stock, worth $12.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

405,659

Previous 78,730 415.25%

Holding current value

$12.1 Million

Previous $1.9 Million 498.52%

% of portfolio

0.03%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $7.52 Million - $9.33 Million	326,929 Added 415.25%	405,659 $11.4 Million
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $4.99 Million - $5.86 Million	-215,045 Reduced 73.2%	78,730 $1.9 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $3.56 Million - $4.39 Million	-134,900 Reduced 31.47%	293,775 $7.95 Million
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $17.8 Million - $21.8 Million	-760,514 Reduced 63.95%	428,675 $11.9 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $6.64 Million - $7.82 Million	244,470 Added 25.88%	1,189,189 $33.3 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $13.4 Million - $15.8 Million	471,108 Added 99.47%	944,719 $29.6 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $10.8 Million - $12.4 Million	-426,824 Reduced 47.4%	473,611 $13.4 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $8.3 Million - $9.93 Million	378,373 Added 72.48%	900,435 $23.5 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $3.84 Million - $5.57 Million	174,717 Added 50.3%	522,062 $11.7 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $2.99 Million - $3.46 Million	113,235 Added 48.37%	347,345 $10.3 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $1.12 Million - $1.36 Million	48,601 Added 26.2%	234,110 $6.16 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $6.27 Million - $9.36 Million	-291,915 Reduced 61.14%	185,509 $4.32 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $820,777 - $1.13 Million	-35,121 Reduced 6.85%	477,424 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $9.63 Million - $12.9 Million	512,545 New	512,545 $12.6 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $4.84 Million - $6.16 Million	-265,515 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $1.16 Million - $1.66 Million	75,133 Added 39.46%	265,515 $5.3 Million
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $4.97 Million - $6.36 Million	-307,856 Reduced 61.79%	190,382 $3.16 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $7.09 Million - $10.3 Million	-532,776 Reduced 51.67%	498,238 $9.67 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $8.36 Million - $13.6 Million	-639,915 Reduced 38.3%	1,031,014 $14.9 Million
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $14.9 Million - $18.7 Million	861,081 Added 106.33%	1,670,929 $34.1 Million
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $12.2 Million - $15.1 Million	-622,833 Reduced 43.47%	809,848 $15.8 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $17.3 Million - $30 Million	803,518 Added 127.71%	1,432,681 $32.3 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $4.25 Million - $5.46 Million	149,705 Added 31.22%	629,163 $23 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $10.6 Million - $16.9 Million	378,964 Added 377.1%	479,458 $14.1 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $3.88 Million - $4.63 Million	100,494 New	100,494 $4.27 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $353,520 - $447,653	-8,716 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $11 Million - $13.8 Million	-205,556 Reduced 95.93%	8,716 $505,000
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $10.2 Million - $11.9 Million	214,272	214,272 $11.7 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Alkermes Plc. Transaction History